Daratumumab Confirmed as SOC for AL Amyloidosis ...Middle East

Medscape - News
Final results in phase 3 Andromeda trial confirmed daratumumab regimen as standard of care for newly diagnosed AL amyloidosis. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Daratumumab Confirmed as SOC for AL Amyloidosis )

Also on site :